Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-29

Clinical Trial Update: An Observational Study to Assess the Real-World Effectiveness of Upadacitinib in Adult Participants With Rheumatoid Arthritis

View source ↗

Summary

An observational real-world study assessing the effectiveness of upadacitinib in adults with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RINVOQ (Upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Status: COMPLETED